chr16-90006418-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001042610.3(DBNDD1):c.394G>A(p.Glu132Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000274 in 1,604,444 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E132G) has been classified as Uncertain significance.
Frequency
Consequence
NM_001042610.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152100Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000336 AC: 8AN: 238398Hom.: 0 AF XY: 0.0000230 AC XY: 3AN XY: 130474
GnomAD4 exome AF: 0.0000289 AC: 42AN: 1452226Hom.: 0 Cov.: 30 AF XY: 0.0000304 AC XY: 22AN XY: 722824
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74424
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.454G>A (p.E152K) alteration is located in exon 4 (coding exon 4) of the DBNDD1 gene. This alteration results from a G to A substitution at nucleotide position 454, causing the glutamic acid (E) at amino acid position 152 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at